Spectrum Pharmaceuticals Inc

RHUMBLINE ADVISERS

Report date

6/30/2023

Quarter

2023 Q2

Filed

8/8/2023

Shares

3,600

Value ($000)

3

Weight

0.0%

2013 Q4 - 2023 Q2 (14 filings)

Shares History

History scope: non-option holdings only (PUT/CALL rows excluded).

All 13F Holders	Filing date	Value ($000s)	% of Holdings	Shares	Reporting period
2023 Q2	8/8/2023	3	0.0%	3,600	6/30/2023
2022 Q1	5/12/2022	210	0.0%	162,991	3/31/2022
2021 Q4	2/10/2022	527	0.0%	414,797	12/31/2021
2021 Q3	11/12/2021	882	0.0%	404,538	9/30/2021
2021 Q2	8/5/2021	1,690	0.0%	450,550	6/30/2021
2021 Q1	5/6/2021	1,643	0.0%	503,919	3/31/2021
2020 Q4	2/10/2021	1,679	0.0%	492,479	12/31/2020
2020 Q3	11/12/2020	1,743	0.0%	427,223	9/30/2020
2020 Q2	8/13/2020	1,305	0.0%	385,979	6/30/2020
2020 Q1	5/6/2020	881	0.0%	378,019	3/31/2020
2019 Q4	2/5/2020	1,309	0.0%	359,681	12/31/2019
2014 Q2	8/6/2014	713	0.0%	87,750	6/30/2014
2014 Q1	5/6/2014	713	0.0%	90,944	3/31/2014
2013 Q4	2/3/2014	828	0.0%	93,564	12/31/2013